Spyre Therapeutics, Inc. - Filer Information

Symbol
SYRE on Nasdaq
Entity
Company
CIK
0001636282
EIN
464312787
Business address
221 Crescent Street, Building 23, Suite 105, 02453 Waltham, MA
Phone
6176515940
State of incorporation
DE
Fiscal year end
December 31
Category
Non-accelerated filer
Smaller reporting company
Former names
Aeglea BioTherapeutics, Inc. (to 11/24/2023)
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company